LifeStance Health Group, Inc. se especializa en brindar servicios de atención de salud mental ambulatoria a través de su red de subsidiarias. ...
Plutux no es un asesor de inversiones. Los datos de mercado y el análisis generado por IA son solo informativos y educativos, no asesoramiento de inversión. Aviso legal
BPA est. $0.04 · Ingresos $431.36M · 4 analistas
BPA est. $0.04 · Ingresos $438.10M · 4 analistas
BPA est. $0.16 · Ingresos $1.71B · 5 analistas
BPA est. $0.07 · Ingresos $460.22M · 1 analistas
| Métrica | Último | InteranualYoY significa Year-over-Year (interanual). Compara el último valor anual con el valor anual anterior para mostrar la fortaleza de la tendencia a largo plazo. | TrimestralQoQ significa Quarter-over-Quarter (intertrimestral). Compara el último trimestre con el trimestre inmediatamente anterior para mostrar cambios de impulso a corto plazo. |
|---|---|---|---|
| IngresosEl dinero total que entró por la puerta principal al vender cosas, antes de pagar una sola factura. Piensa en esto como el gran total de cada compra con tarjeta de los clientes. (YoY compara el rendimiento de este año con el del año pasado, mientras que QoQ compara los tres meses actuales con los tres anteriores). | $1.4B | +13.9% | +7.9% |
| Beneficio netoEl resultado final absoluto. Si la empresa pagara a cada proveedor, empleado, banquero y recaudador de impuestos, este es el dinero real que queda en su bolsillo al final del día. | $9.7M | +116.8% | +65.8% |
| Margen brutoEl margen básico. Si venden unas zapatillas de 100 dólares, este porcentaje indica cuánto de ese precio es ganancia justo después de pagar el caucho y los cordones, pero antes de pagar el alquiler de la tienda o los anuncios de televisión. | +32.4% | +0.6% | +4.3% |
| Margen operativoLa puntuación de eficiencia del 'trabajo diario'. De cada dólar que gasta un cliente, esto muestra cuántos centavos mantiene la empresa después de fabricar el producto Y pagar todos los gastos generales corporativos (como salarios, marketing y mantener las luces encendidas). | +1.7% | +167.1% | +27.5% |
| Margen netoEl porcentaje final que se lleva a casa. Cuando se eliminan todos los costos concebibles, impuestos y pagos de intereses, este es el número exacto de centavos que la empresa realmente se queda de cada dólar en ventas. | +0.7% | +114.8% | +53.6% |
| Flujo de caja libreEl santo grial del efectivo corporativo. Es el dinero físico gastable que queda después de que el negocio paga sus operaciones diarias Y compra las actualizaciones grandes y costosas (como nuevas fábricas o servidores) que necesita para sobrevivir. Este es el dinero 'libre' que pueden usar para pagar dividendos o recomprar acciones. | $110.0M | +28.4% | +293.5% |
| Margen FCFLa tasa definitiva de conversión de efectivo. Muestra qué tan buena es la empresa para convertir ventas regulares directamente en efectivo frío, duro y gastable. Un porcentaje alto significa que el negocio es una auténtica máquina de imprimir dinero. | +7.7% | +12.8% | +264.7% |
| Deuda/PatrimonioEl indicador de riesgo financiero. Compara cuánto del imperio de la empresa se construyó con dinero prestado (préstamos) frente al dinero propio de los propietarios (accionistas). Un número alto significa que están muy apalancados y juegan un juego más arriesgado; un número bajo significa que juegan a lo seguro. | 12.8% | -62.0% | +2.3% |
| Ratio corrienteLa verificación de supervivencia de 12 meses. Simplemente compara el efectivo que tienen ahora mismo (más cosas que pueden convertirse rápidamente en efectivo) con las facturas inmediatas que absolutamente deben pagar este año. Una puntuación superior a 1 significa que tienen suficiente en la billetera para cubrir las próximas facturas sin entrar en pánico. | 1.65x | +21.0% | -7.3% |
| Activos totalesEl tamaño absoluto del imperio de la empresa. Agrupa absolutamente todo lo valioso que poseen, desde el efectivo en la caja registradora y el inventario en el almacén, hasta las patentes de software en la bóveda y las fábricas en el suelo. | $2.2B | +4.0% | +1.7% |
| Métrica | Anual (real vs estimado) | Sorpresa anual | Trimestral (real vs estimado) | Sorpresa trimestral |
|---|---|---|---|---|
| EPS Surprise | 0.02 vs -0.00 | +561.5% | 0.06 vs 0.04 | +62.7% |
| Revenue Surprise | $1.4B vs $1.4B | +0.3% | $435.4M vs $431.4M | +0.9% |
| Fecha | Ejecutivo | Cargo | Valor | Lado | Acciones | Precio |
|---|---|---|---|---|---|---|
| Aug 24, 2026 | Varanakis Ann | officer: Chief People Officer | Common Stock | D | 8,156 | $12.16 |
| Aug 14, 2026 | DeLuca Teresa | director | Common Stock | D | 7,500 | $12.68 |
| Aug 13, 2026 | DeLuca Teresa | director | Common Stock | D | 20,441 | $12.23 |
| Aug 11, 2026 | Burdick Kenneth A | director | Common Stock | D | 500,000 | $11.51 |
| Aug 10, 2026 | Paunovich Vukasin | officer: Chief Technology Officer | Common Stock | D | 44,394 | $10.85 |
Operator: Hello, and thank you for standing by. My name is Bella, and I will be your conference operator today. At this time, I would like to welcome everyone to LifeStance Health Second Quarter 2026 Earnings Call. [Operator Instructions] I would now like to turn the conference over to Monica Prokocki. You may begin. Monica Prokocki: Thank you, operator. Good morning, everyone, and welcome to LifeStance Health's second quarter 2026 earnings conference call. I'm Monica Prokocki, Vice President of Finance and Investor Relations. Joining me today are Dave Bourdon, Chief Executive Officer; and Ryan McGroarty, Chief Financial Officer. We issued the earnings release and presentation before the market open this morning. Both are available on the Investor Relations section of our website, investor.lifestance.com. In addition, a replay will be available following the call. Before turning over to management for their prepared remarks, please direct your attention to the disclaimers about forward-looking statements included in the earnings press release and SEC filings. Today's remarks contain forward-looking statements, including statements about our financial performance outlook, business model and strategy. Those statements involve risks, uncertainties and other factors, as noted in our periodic filings with the SEC that could cause actual results to differ materially. Please note that we report results using non-GAAP financial measures, which we believe provide additional information for investors to help facilitate comparison of current and past performance. A reconciliation to the most directly comparable GAAP measures is included in the earnings press release tables and presentation appendix. Unless otherwise noted, all results are compared to the comparable period in the prior year. At this time, I'll turn the call over to Dave Bourdon, CEO of LifeStance. Dave? David Bourdon: Thanks, Monica, and thank you all for joining us today. This was another exceptional quarter for LifeStance. We exceeded each of our guided metrics for the quarter, delivering remarkable revenue growth of over 26% and adjusted EBITDA margins that exceeded 15%. Given the outperformance in the quarter, we are again raising our full year guidance across all metrics. Ryan will provide the details on our improved view of 2026 later. Regarding operational execution, we continue to grow our clinician base now at over 8,500 clinicians as our value proposition continues to resonate. Clinician productivity also remained strong in the quarter, reflecting the power of our operating model and discipline. As for specialty services, we continue to expand our reach as we launched TMS and Spravato in additional centers to support patients with treatment-resistant depression and to drive clinically meaningful improvements in outcomes. Turning to technology. We continue to deploy digital, AI-enabled and workflow automation tools that improve patient access, enhance the clinician experience and …
| Nombre | Cargo | Remuneración | Género | Año de nacimiento | Estado |
|---|---|---|---|---|---|
Ryan Bruce McGroarty | Chief Financial Officer & Treasurer | USD 1,515,425 | Male | 1973 | Active |
David Patrick Bourdon | Chief Executive Officer & Director | USD 1,387,757 | Male | 1969 | Active |
Kenneth Alan Burdick | Executive Chairman | USD 650,154 | Male | 1959 | Active |
Vukasin Paunovich | Chief Technology Officer | USD 644,201 | Male | 1972 | Active |
Ann Varanakis | Chief People Officer | USD 558,251 | Female | 1978 | Active |
Ryan Pardo | Chief Legal Officer & Secretary | USD 558,251 | Male | 1977 | Active |
Lisa Keise Miller | Chief Operating Officer & Principal Operating Officer | — | Female | 1974 | Active |
Monica Prokocki | Vice President of Investor Relations | — | Female | — | Active |
Brooke Matthews | Director of Public Relations | — | — | — | Active |
Richard Hall | Chief Shared Services Officer | — | Male | — | Active |
SCOTTSDALE, Ariz., Sept. 01, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced that management will present at the following upcoming investor conferences.
Canada Pension Plan Investment Board acquired a new stake in shares of LifeStance Health Group, Inc. (NASDAQ: LFST) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 149,000 shares of the company's stock, valued at approximately $1,596,000. Other institutional investors have also
An aging population and growing telehealth and AI adoption support the Zacks Medical - Outpatient and Home Healthcare industry. DVA, LFST, OPCH and AVAH stand to benefit.
Low-leverage stocks like NVIDIA and Valero Energy could offer investors resilience amid market volatility and uncertainty.
Does LifeStance Health Group (LFST) have what it takes to be a top stock pick for momentum investors? Let's find out.
